Scribe Therapeutics has secured more than $25 million in CIRM [...]

Resolution Therapeutics has expanded its regenerative macrophage therapy pipeline with [...]

Gesynta Pharma has randomised half of the planned patients in [...]

Sysmex Europe has launched its HISCL automated immunoassay platform for [...]

spliesense-cystic-fibrosis-foundation-spl84-phase2b SpliSense has secured up to $13 million in funding [...]

Mabion has signed a letter of intent with French technology [...]

Innovative Molecules has expanded its virology pipeline with a new [...]

Confo Therapeutics has presented preclinical data supporting the development of [...]

CERo Therapeutics Holdings, Inc has shared a Phase 1 update [...]

Lonza has entered an exclusive licensing agreement with Antharis Therapeutics [...]